APA citiranje

Baron, K. T., Macha, S., Broedl, U. C., Nock, V., Retlich, S., & Riggs, M. (2016). Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes. Diabetes Ther.

Citação norma Chicago

Baron, Kyle T., Sreeraj Macha, Uli C. Broedl, Valerie Nock, Silke Retlich, and Matthew Riggs. "Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients With Type 2 Diabetes." Diabetes Ther 2016.

MLA citiranje

Baron, Kyle T., et al. "Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients With Type 2 Diabetes." Diabetes Ther 2016.